AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 166 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $13,000 | +44.4% | 40,606 | +64.8% | 0.00% | – |
Q2 2022 | $9,000 | -81.2% | 24,634 | +30.0% | 0.00% | – |
Q3 2020 | $48,000 | -61.9% | 18,947 | +49.8% | 0.00% | -100.0% |
Q2 2018 | $126,000 | -60.0% | 12,645 | -61.8% | 0.00% | 0.0% |
Q1 2018 | $315,000 | +76.0% | 33,099 | +174.7% | 0.00% | 0.0% |
Q4 2017 | $179,000 | -97.9% | 12,049 | -98.5% | 0.00% | -98.1% |
Q2 2015 | $8,524,000 | +453.1% | 828,357 | +497.3% | 0.05% | +333.3% |
Q1 2015 | $1,541,000 | -42.2% | 138,676 | -39.4% | 0.01% | -50.0% |
Q4 2014 | $2,665,000 | – | 228,934 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 7,031,283 | $95,485,000 | 5.72% |
GREAT POINT PARTNERS LLC | 3,510,073 | $47,667,000 | 3.81% |
Logos Global Management LP | 1,200,000 | $16,296,000 | 3.26% |
DAFNA Capital Management LLC | 762,666 | $10,357,000 | 2.99% |
Baupost Group | 15,000,000 | $203,700,000 | 2.54% |
Nantahala Capital Management | 6,101,111 | $82,853,000 | 2.50% |
Abrams Capital Management | 5,656,462 | $76,815,000 | 2.48% |
Novo Holdings A/S | 1,987,506 | $26,990,000 | 1.74% |
Stanley-Laman Group, Ltd. | 316,933 | $4,304,000 | 1.04% |
Integral Health Asset Management, LLC | 250,000 | $3,395,000 | 1.02% |